Lilly Asia Ventures is a leading biomedical venture capital firm focusing on investments in the life sciences and healthcare sectors in Asia, particularly in China. The firm was founded in 2008 and has since expanded its presence with offices in Shanghai, Hong Kong, and San Diego. LAV leverages its strategic partnership with Eli Lilly and Company to provide portfolio companies with deep industry expertise, global network resources, and strategic advice.

COM:LILLYASIAVENTURES

Lilly Asia Ventures

market

industry

website

crunchbase

linkedin

invested in

Metrics